Daniela Meco Selected Research

Type I DNA Topoisomerases (Topoisomerase I)

7/2012

The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Meco Research Topics

Disease

15	Neoplasms (Cancer) 01/2023 - 08/2003
6	Neuroblastoma 12/2012 - 10/2005
5	Glioma (Gliomas) 01/2023 - 12/2006
4	Ependymoma 02/2021 - 09/2012
4	Medulloblastoma 01/2014 - 06/2009
4	Rhabdomyosarcoma 07/2012 - 09/2005
2	Carcinoma (Carcinomatosis) 01/2023 - 09/2003
2	Primitive Neuroectodermal Tumors (PNET) 12/2012 - 06/2009
2	Sarcoma (Soft Tissue Sarcoma) 07/2012 - 08/2003
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Intestinal helminthiasis 01/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Adrenocortical Carcinoma 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Carcinogenesis 01/2021
1	Weight Loss (Weight Reduction) 12/2012
1	Glioblastoma (Glioblastoma Multiforme) 12/2006
1	Necrosis 09/2003
1	Fibrosarcoma 08/2003
1	Neoplasm Metastasis (Metastasis) 08/2003

Drug/Important Bio-Agent (IBA)

4	Irinotecan (Camptosar)FDA LinkGeneric 12/2012 - 09/2005
3	Phosphotransferases (Kinase)IBA 01/2021 - 10/2005
3	CamptothecinIBA 12/2012 - 10/2005
3	ErbB Receptors (EGF Receptor)IBA 09/2012 - 12/2006
3	TrabectedinIBA 09/2005 - 08/2003
2	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2014
2	Nerve Growth Factor (NGF)IBA 01/2021 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 11/2017 - 09/2012
2	namitecanIBA 12/2012 - 07/2012
2	Gefitinib (Iressa)FDA Link 09/2012 - 06/2009
2	AEE 788 (AEE788)IBA 09/2012 - 10/2010
2	RetinoidsIBA 08/2012 - 03/2007
2	3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA 08/2012 - 03/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012 - 10/2010
2	ST 1481 (Gimatecan)IBA 09/2010 - 10/2005
2	Topotecan (Hycamtin)FDA LinkGeneric 03/2007 - 10/2005
2	Imatinib Mesylate (Gleevec)FDA Link 03/2007 - 10/2005
1	benzimidazoleIBA 01/2023
1	Mebendazole (Anti-Worm)FDA Link 01/2023
1	Antiparasitic Agents (Antiparasitics)IBA 01/2023
1	OTX015IBA 02/2021
1	Histones (Histone)IBA 02/2021
1	trkA ReceptorIBA 01/2021
1	AZD 6244IBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	TropomyosinIBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 11/2017
1	MitogensIBA 11/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2017
1	Etoposide (VP 16)FDA LinkGeneric 08/2014
1	Temozolomide (Temodar)FDA LinkGeneric 08/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2014
1	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2014
1	NestinIBA 01/2014
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2014
1	Estrogen ReceptorsIBA 01/2014
1	Estrogens (Estrogen)FDA Link 01/2014
1	Glial Fibrillary Acidic ProteinIBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 09/2012
1	Mitogen-Activated Protein Kinase 3IBA 09/2012
1	Caspase 8 (Caspase-8)IBA 08/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2012
1	Cytostatic AgentsIBA 08/2012
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2012
1	ChemokinesIBA 07/2012
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2010
1	LactonesIBA 09/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2006
1	Platelet-Derived Growth Factor alpha ReceptorIBA 12/2006
1	NucleotidesIBA 12/2006
1	tyrosine receptor (receptor, tyrosine)IBA 10/2005
1	Tyrosine (L-Tyrosine)FDA Link 10/2005
1	BilirubinIBA 09/2003
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2003
1	Alkaline PhosphataseIBA 09/2003
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2003

Therapy/Procedure

4	Therapeutics 01/2023 - 08/2012
1	Drug Therapy (Chemotherapy) 01/2023
1	Radiotherapy 01/2023